The DOI matches its Crossref record; 212 of the 218 references it cites were found in a registry or an index, and 1 are not checked yet.
Xpert ® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
Open accessAbstract
BACKGROUND: MTB/RIF (Xpert) is a World Health Organization (WHO)-recommended, rapid, automated, nucleic acid amplification assay that is used widely for simultaneous detection of Mycobacterium tuberculosis complex and rifampicin resistance in sputum specimens. This Cochrane Review assessed the accuracy of Xpert in extrapulmonary specimens. OBJECTIVES: To determine the diagnostic accuracy of Xpert a) for extrapulmonary TB by site of disease in people presumed to have extrapulmonary TB; and b) for rifampicin resistance in people presumed to have extrapulmonary TB. SEARCH METHODS: We searched the Cochrane Infectious Diseases Group Specialized Register, MEDLINE, Embase, Science Citation Index, Web of Science, Latin American Caribbean Health Sciences Literature (LILACS), Scopus, ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform, the International Standard Randomized Controlled Trial Number (ISRCTN) Registry, and ProQuest up to 7 August 2017 without language restriction. SELECTION CRITERIA: We included diagnostic accuracy studies of Xpert in people presumed to have extrapulmonary TB. We included TB meningitis and pleural, lymph node, bone or joint, genitourinary, peritoneal, pericardial, and disseminated TB. We used culture as the reference standard. For pleural TB, we also included a composite reference standard, which defined a positive result as the presence of granulomatous inflammation or a positive culture result. For rifampicin resistance, we used culture-based drug susceptibility testing or MTBDRplus as the reference standard. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data, assessed risk of bias and applicability using the QUADAS-2 tool. We determined pooled predicted sensitivity and specificity for TB, grouped by type of extrapulmonary specimen, and for rifampicin resistance. For TB detection, we used a bivariate random-effects model. Recognizing that use of culture may lead to misclassification of cases of extrapulmonary TB as 'not TB' owing to the paucibacillary nature of the disease, we adjusted accuracy estimates by applying a latent class meta-analysis model. For rifampicin resistance detection, we performed univariate meta-analyses for sensitivity and specificity separately to include studies in which no rifampicin resistance was detected. We used theoretical populations with an assumed prevalence to provide illustrative numbers of patients with false positive and false negative results. MAIN RESULTS: We included 66 unique studies that evaluated 16,213 specimens for detection of extrapulmonary TB and rifampicin resistance. We identified only one study that evaluated the newest test version, Xpert MTB/RIF Ultra (Ultra), for TB meningitis. Fifty studies (76%) took place in low- or middle-income countries. Risk of bias was low for patient selection, index test, and flow and timing domains and was high or unclear for the reference standard domain (most of these studies decontaminated sterile specimens before culture inoculation). Regarding applicability, in the patient selection domain, we scored high or unclear concern for most studies because either patients were evaluated exclusively as inpatients at tertiary care centres, or we were not sure about the clinical settings.Pooled Xpert sensitivity (defined by culture) varied across different types of specimens (31% in pleural tissue to 97% in bone or joint fluid); Xpert sensitivity was > 80% in urine and bone or joint fluid and tissue. Pooled Xpert specificity (defined by culture) varied less than sensitivity (82% in bone or joint tissue to 99% in pleural fluid and urine). Xpert specificity was ≥ 98% in cerebrospinal fluid, pleural fluid, urine, and peritoneal fluid.Xpert testing in cerebrospinal fluidXpert pooled sensitivity and specificity (95% credible interval (CrI)) against culture were 71.1% (60.9% to 80.4%) and 98.0% (97.0% to 98.8%), respectively (29 studies, 3774 specimens; moderate-certainty evidence).For a population of 1000 people where 100 have TB meningitis on culture, 89 would be Xpert-positive: of these, 18 (20%) would not have TB (false-positives); and 911 would be Xpert-negative: of these, 29 (3%) would have TB (false-negatives).For TB meningitis, ultra sensitivity and specificity against culture (95% confidence interval (CI)) were 90% (55% to 100%) and 90% (83% to 95%), respectively (one study, 129 participants).Xpert testing in pleural fluidXpert pooled sensitivity and specificity (95% CrI) against culture were 50.9% (39.7% to 62.8%) and 99.2% (98.2% to 99.7%), respectively (27 studies, 4006 specimens; low-certainty evidence).For a population of 1000 people where 150 have pleural TB on culture, 83 would be Xpert-positive: of these, seven (8%) would not have TB (false-positives); and 917 would be Xpert-negative: of these, 74 (8%) would have TB (false-negatives).Xpert testing in urineXpert pooled sensitivity and specificity (95% CrI) against culture were 82.7% (69.6% to 91.1%) a
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“For lymph node aspirate, we provide evidence using a composite reference because, based on findings from the original review (Kohli 2018), we believe a composite reference standard is preferable for estimating accuracy.”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Kohli 2018
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In the previous review (Kohli 2018), we added post hoc a sensitivity analysis limiting inclusion to studies that used one specimen per participant. In this review, we performed a similar sensitivity analysis for Xpert Ultra.”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Kohli 2018
The cited source says what the claim attributes to it.
In the citing paper
“However, for Xpert MTB/RIF in CSF, in comparison with all studies, (sensitivity of 71.1% (60.9 to 80.4), and specificity of 98.0% (97.0 to 98.8)), studies that evaluated only one specimen per participant had lower pooled sensitivity at 63.5% (47.6 to 76.3) and lower pooled specificity at 96.1% (94.2 to 97.4).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Kohli 2018
The cited source says what the claim attributes to it.
In the citing paper
“For Xpert MTB/RIF, in the original review we performed sensitivity analyses by type of extrapulmonary specimen and found that for most analyses, the sensitivity analyses made little difference to any of these findings (Kohli 2018).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Kohli 2018
The cited source says what the claim attributes to it.
In the citing paper
“We previously reported that for CSF, of 2096 tests performed, the pooled proportion of inconclusive Xpert MTB/RIF results was 0.9% (95% CrI 0.3 to 1.9) (Kohli 2018).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Kohli 2018
The cited source says what the claim attributes to it.
In the citing paper
“We previously reported that for lymph node aspirates, in the 1134 tests performed, the pooled proportion of inconclusive Xpert MTB/RIF results was 1.0% (95% CrI 0.4 to 2.0) (Kohli 2018).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Kohli 2018
The cited source says what the claim attributes to it.
In the citing paper
“We previously reported that for pleural fluid, of 1416 tests performed the pooled proportion of inconclusive Xpert MTB/RIF results was 1.2% (95% CrI 0.4 to 2.6) (Kohli 2018).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Kohli 2018
The cited source says what the claim attributes to it.
In the citing paper
“We previously reported that for rifampicin resistance testing, of 1003 tests performed, the pooled proportion of indeterminate Xpert MTB/RIF results was 2.6% (95% CrI 1.4 to 4.3) (Kohli 2018).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Kohli 2018
The cited source says what the claim attributes to it.
In the citing paper
“For Xpert MTB/RIF, we previously reported that in 10 studies involving 6975 specimens with 141 NTMs, Xpert MTB/RIF was negative in all specimens (Kohli 2018).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Kohli 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility
Lunn, D. J., Thomas, A., Best, N., & Spiegelhalter, D. J. (2000) · Statistics and Computing · doi:10.1023/a:1008929526011 · Cited by 5,397
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2015) · BMJ · doi:10.1136/bmj.h5527 · Cited by 3,660
Reitsma, J. B., Glas, A. S., Rutjes, A. W. S., Scholten, R. J. P. M., Bossuyt, P. M., & Zwinderman, A. H. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.02.022 · Cited by 3,369
The BUGS project: evolution, critique and future directions
Lunn, D., Spiegelhalter, D., Thomas, A., & Best, N. (2009) · Statistics in Medicine · doi:10.1002/sim.3680 · Cited by 1,876
Grading quality of evidence and strength of recommendations for diagnostic tests and strategies
Schünemann, H. J., Oxman, A. D., Brozek, J., Glasziou, P., Jaeschke, R., Vist, G. E., Williams, J. W., Kunz, R., Craig, J., Montori, V. M., et al. (2008) · BMJ · doi:10.1136/bmj.39500.677199.ae · Cited by 1,782
Nahid, P., Dorman, S. E., Alipanah, N., Barry, P. M., Brożek, J., Cattamanchi, A., Chaisson, L. H., Chaisson, R. E., Daley, C. L., Grzemska, M., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw376 · Cited by 1,537
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.16141 · Cited by 1,524
Flagged first, then by citations
5 of the 218 references couldn’t be matched to a known paper.
Research works printed but not linked: 13
- Jing, 2017, Evaluation of Xpert MTB/RIF in detection of pulmonary and extrapulmonary tuberculosis cases in China, International Journal of Clinical and Experimental Pathology, 10, 4847
- Peñata, 2016, Molecular diagnosis of extrapulmonary tuberculosis and sensitivity to rifampicin with an automated real-time method, Biomedica, 36 Suppl 1, 78
- Bemba, 2017, Performance of GeneXpert MTB / RIF in the diagnosis of pleural tuberculosis in Brazzaville: a preliminary report, Health Sciences and Diseases, 18, 21
- Gascoyne-Binzi, 2012, Comparison of on-demand PCR testing for Mycobacterium tuberculosis with culture and batched PCR, Clinical Microbiology and Infection, 18, 543
- Ioannidis, 2010, Tuberculosis resistance detection rate to the two main anti-TB drugs, isoniazid and rifampicin, using molecular techniques: experience of the Hellenic National Reference Center for Mycobacteria. [Greek], Acta Microbiologica Hellenica, 55, 175
- Mishra, 2017, Study of diagnostic utility of Xpert MTB/RIF test on pleural fluid in the evaluation of patients presenting with pleural tuberculosis in high prevalence setting, American Journal of Respiratory and Critical Care Medicine, 195, A2088
- Veritas Health Innovation Covidence systematic review software. Available at www.covidence.org 2017
- Gupta-Wright A Corbett EL van Oosterhout JJ Wilson DK Grint D Alufandika-Moyo M Urine-based screening for tuberculosis: a randomized trial in HIV-positive inpatients (the STAMP trial) Conference on retroviruses and opportunistic infections (CROI). www.croiconference.org/sessions/urine-based-screening-tuberculosis-randomized-trial-hiv-positive-inpatients Boston 2018 38LB
- Macaskill P Gatsonis C Deeks JJ Harbord RM Takwoingi Y Chapter 10: Analysing and presenting results. In: Deeks JJ, Bossuyt PM, C Gatsonis (editors). Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. The Cochrane Collaboration, 2010 http://srdta.cochrane.org/
- Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014
- Schünemann HJ Oxman AD Gunn EV Higgins JPT Deeks JL Glasziou P Chapter 11. Presenting results and "Summary of findings" tables. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
- Boyle, 2017, Tuberculosis Diagnostics Technology and Market Landscape
- World Health Organization, 2017, Global tuberculosis report
Cited by
Sorted by citations
Items 101–200 of 244
Lymphadenopathy in a tuberculosis-endemic area: Diagnostic pitfalls and suggested approach
Antel, K. R., & Verburgh, E. R. (2019) · South African Medical Journal · doi:10.7196/samj.2019.v109i10.14361 · Cited by 10
Yan, Z., Wang, H., Zheng, W., & Hu, Z.-D. (2022) · Journal of Tropical Medicine · doi:10.1155/2022/4348063 · Cited by 10
Oreskovic, A. K., Waalkes, A., Holmes, E. A., Rosenthal, C. A., Wilson, D., Shapiro, A. E., Drain, P. K., Lutz, B. R., & Salipante, S. J. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.09.042 · Cited by 9
Abdominal Tuberculosis Mimicking Ovarian Cancer: A Case Report and Review of the Literature
Rinaldi, I., Muthalib, A., Gosal, D., Wijayadi, T., Sutedja, B., Setiawan, T., Gunawan, A., Susanto, N., Magdalena, L., Handjari, D. R., et al. (2022) · International Medical Case Reports Journal · doi:10.2147/imcrj.s348434 · Cited by 9
Ndege, R. C., Ngome, O., Vanobberghen, F. M., Bani, F., Temba, Y., Wilson, H. I., Hella, J., Gingo, W., Sasamalo, M., Mnzava, D., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac871 · Cited by 9
Sun, B., & Sun, Y. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-21-913 · Cited by 9
Chapter 7: Extra-pulmonary tuberculosis
Barss, L., Connors, W. J. A., & Fisher, D. (2022) · Canadian Journal of Respiratory Critical Care and Sleep Medicine · doi:10.1080/24745332.2022.2036073 · Cited by 9
Tuberculosis Diagnosis and Detection of Drug Resistance: A Comprehensive Updated Review
Tawfick, M. M., Badawy, M. S. E. M., Taleb, M. H., & Menofy, N. G. E. (2023) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.17.4.56 · Cited by 9
Lin, B.-W., Hong, J.-C., Jiang, Z.-J., Zhang, W., Fan, Q.-C., & Yao, X.-P. (2024) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001818 · Cited by 9
Sharma, S. K., & Mohan, A. (2019) · Springer eBooks · doi:10.1007/978-981-32-9413-4_4 · Cited by 8
Beltran, C. G. G., Venter, R., Mann, T. N., Davis, J. H., Kana, B. D., & Walzl, G. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1065893 · Cited by 8
Zhou, L., Zou, X., Yong, Y., & Hu, Q. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080904 · Cited by 9
Aurílio, R. B., Marseli, V. V., Malaquias, T. D. S. S., Kritski, A. L., & Sant’Anna, C. C. (2020) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0104-2020 · Cited by 8
Mu, J., Liu, Z., Zhang, C., Wang, C., Du, W., Lin, H., Li, K., Song, J., Che, N., & Liu, H. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa203 · Cited by 8
Ma, J., Liu, H., Wang, J., Li, W., Fan, L., & Sun, W. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s342744 · Cited by 9
Liu, P., Wang, Y., Hao, S., & Qin, Y. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04052-x · Cited by 7
An evaluation of Composite Reference Standard (CRS) for diagnosis of Female Genital Tuberculosis
Sharma, J. B., Jain, S., Dharmendra, S., Singh, U. B., Soneja, M., Kulshrestha, V., & Vanamail, P. (2022) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2022.03.014 · Cited by 7
Mahajan, N. (2020) · US Endocrinology · doi:10.17925/use.2020.16.2.109 · Cited by 7
Mokaddas, E. M., Ahmad, S., & Eldeen, H. S. (2021) · Medical Principles and Practice · doi:10.1159/000515254 · Cited by 7
Laparoscopic evaluation of female genital tuberculosis in infertility: An observational study
Sharma, J. B., Sharma, S. K., Dharmendra, S., Singh, U. B., Kumar, S., & Roy, K. K. (2023) · International Journal of Microbiology Research · doi:10.4103/ijmr.ijmr_2498_21 · Cited by 7
Tan, D. T. M., & See, K. C. (2024) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v13.i2.91435 · Cited by 6
Kohli, M., Inbaraj, L. R., Salomon, A., Scandrett, K., Korobitsyn, A., Ismail, N. A., Srinivasalu, V. A., Daniel, J., Steingart, K. R., & Takwoingi, Y. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub4 · Cited by 6
Self-citationA Rare Case of Flexor Tenosynovitis Due to Tuberculosis in Hand and Wrist: a Case Report
KORKMAZ, M., Tolu, S., & Şimşek, S. (2021) · Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca · doi:10.55095/achot2021/038 · Cited by 6
Cost-effectiveness of TB diagnostic technologies in Ethiopia: a modelling study
Assebe, L. F., Kumsa, A., Fikadu, L., Alemu, B., Baruda, Y. S., & Jiao, B. (2024) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-024-00544-1 · Cited by 6
Park, M., Kumar, K., Coleman, M., Martin, L., Russell, G., Scheelbeek, P., Lalvani, A., Satta, G., & Kon, O. M. (2024) · Thorax · doi:10.1136/thorax-2023-220647 · Cited by 6
Zhang, W., Xu, J., Zhang, L., & Ni, T. (2024) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-024-04913-9 · Cited by 6
Tomaz, A. P. D. O., Raboni, S. M., Kussen, G. M. B., Nogueira, K. D. S., Ribeiro, C. E., & Dalla-Costa, L. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247185 · Cited by 6
Guan, M. J., Zhang, J., Jia, Y., Teng, Y., Cao, X., & Li, Y. (2021) · PubMed Central · Cited by 6
Labetoulle, R., Rigaill, J., Lleres-Vadeboin, M., Grattard, F., Pozzetto, B., Cazorla, C., Botelho-Nevers, É., Boyer, B., Dupieux, C., Laurent, F. J., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00835-21 · Cited by 6
Yu, W., Shen, Y., Zhu, P., & Chen, D. (2022) · Medicine · doi:10.1097/md.0000000000029363 · Cited by 6
Grønningen, E., Nanyaro, M.-W. A., Sviland, L., Ngadaya, E. S., Muller, W., Torres, L., Mfinanga, S., & Mustafa, T. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001317 · Cited by 6
Han, X.-F., Han, C., Jin, F., Wang, J., & Wang, M. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06209-1 · Cited by 6
Assessing the diagnostic accuracy of the Xpert MTB/RIF assay in detecting epididymal tuberculosis
Liu, P., Liu, Y., Wang, Y., Hao, S., & Qin, Y. (2022) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-022-04418-3 · Cited by 6
Recent Developments in Tuberculous Meningitis Pathogenesis and Diagnostics
Cresswell, F. V., Davis, A., Sharma, K., Roy, R. B., Ganiem, A. R., Kagimu, E., Solomons, R., Wilkinson, R. J., Bahr, N. C., & Thương, N. T. T. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15506.2 · Cited by 7
Swaminathan, A., du Cros, P., Achar, J., Kliescikova, J., Mirgayosieva, S., & Pirmahmadzoda, B. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05027-1 · Cited by 6
He, X., Zhang, Y., Zhou, Y., Li, L., & Li, Q. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08734-7 · Cited by 5
Sinha, S., Titiyal, R., Mohapatra, P. R., Palvai, R. K., Kar, I., Mishra, B., Ajayababu, A., Sinha, A., Bhuniya, S., & Pandey, S. (2025) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed10080206 · Cited by 5
Comprehensive review of osteoarticular tuberculosis: from epidemiology to emerging therapies
Kumari, N., Sharma, I., Kumar, D., Goel, K., Singh, V., & Katoch, S. (2025) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20252594 · Cited by 6
Yao, L., Bu, C., Zhang, J., & Zhang, D. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1173368 · Cited by 5
Hiebert, M. R., Sharma, M. K., Rabb, M. J., Karlowsky, L. J., Bergman, K. S., & Soualhine, H. (2024) · Antibiotics · doi:10.3390/antibiotics13070624 · Cited by 5
Lo, C. K.-F., Purych, D. B., Sekirov, I., Khattra, J. S., Hird, T. J., & Masud, S. (2024) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001918 · Cited by 5
Binjomah, A. Z., Alnimr, A. M., Zareah, S. M., Alharbi, S. F., Alasmari, K. S., Aldosari, K., & Alduealej, I. M. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.05.080 · Cited by 5
Li, J., Ouyang, J., Yuan, J., Li, T., Luo, M., Wang, J., & Chen, Y. (2022) · Infectious Diseases of Poverty · doi:10.1186/s40249-022-00953-5 · Cited by 5
Kakinda, M., Tugumisirize, D., Nyombi, A., Mugisha, M., Turyahabwe, S., Walusimbi, S., & Matovu, J. K. B. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275960 · Cited by 5
Chotmongkol, V., Kosallavat, S., Sawanyawisuth, K., Khamsai, S., Kasemsap, N., Vorasoot, N., Kongbunkiat, K., Tiamkao, S., & Chaimanee, P. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-023-03009-5 · Cited by 5
Schutz, C., Ward, A. M., Burton, R., Nicol, M. P., Blumenthal, L., Meintjes, G., & Kerkhoff, A. D. (2019) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v20i1.978 · Cited by 5
Elevated Notch ligands in serum are associated with HIV/TB coinfection
Bermick, J., Lincoln, P., Allen, R., Kunkel, S. L., & Schaller, M. A. (2021) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2021.100258 · Cited by 5
Diagnostic approaches for pancreatic tuberculosis
Wu, C.-X., Xiao, L., Luo, Z.-F., & Shi, S. (2022) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2022.01.004 · Cited by 5
Armstrong, D. T., Tacheny, E. A., Olinger, G. G., Howard, R., Lemmon, M. M., Dasgupta, D., Eisemann, E., & Parrish, N. M. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00778-21 · Cited by 5
FluoroType® MTB en líquido pleural para el diagnóstico de tuberculosis
Bielsa, S., Bernet, A., Civit, C., Acosta, C., Manonelles, A., & Porcel, J. M. (2020) · Revista Clínica Española · doi:10.1016/j.rce.2020.04.010 · Cited by 4
Giudice, A. D., Perna, R., Baldoni, T., Scarano, F., Rosa, A. D., Pontarelli, A., Marco, M. D., Falca, M., Tella, C. D., Atripaldi, L. G., et al. (2021) · Journal of Tuberculosis Research · doi:10.4236/jtr.2021.93021 · Cited by 4
Diagnostic performance analysis of Xpert MTB/RIF in lymph node tuberculosis: A retrospective study
Dai, L., Peng, L., Fang, T., Shao, Y., & Cai, L. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116385 · Cited by 4
Tuberculosis: Diagnostic Challenges in Rural Africa
Masawa, N., Bani, F., & Ndege, R. C. (2019) · Praxis · doi:10.1024/1661-8157/a003355 · Cited by 4
Evaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis
Li, H., He, Z., Liang, J., Li, G., Xie, T., Liu, Y., Li, Z., Feng, X., Xia, Y., & Guo, X. (2020) · BioMed Research International · doi:10.1155/2020/1968487 · Cited by 4
Global trends of research on tuberculous pleurisy over the past 15 years: A bibliometric analysis
Bian, Y., Deng, M., Zhang, Q., & Hou, G. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.937811 · Cited by 4
Badr, O. I., Elrefaey, W. A., Shabrawishi, M., Assaggaf, H. M., & Minshawi, F. (2022) · Multidisciplinary Respiratory Medicine · doi:10.4081/mrm.2022.872 · Cited by 4
Chiang, S. S., & Starke, J. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00134-8 · Cited by 5
Cerebrospinal fluid lactate as a predictive biomarker for tuberculous meningitis diagnosis
de Almeida, S. M., Kussen, G. M. B., Cogo, L. L., & Nogueira, K. D. S. (2022) · Diagnosis · doi:10.1515/dx-2022-0102 · Cited by 4
Darshani, A. G. S., Sathischandra, D. H. H. L., & Perera, M. N. S. K. (2019) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2019.11.011 · Cited by 4
Yu, G., Shen, Y., Xu, X., & Lin, L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250470 · Cited by 5
Mann, T., Minnies, S., Gupta, R. K., Reeve, B. W. P., Nyawo, G. R., Palmer, Z., Naidoo, C. C., Doubell, A. F., Pecoraro, A. J. K., John, T.-J., et al. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2025.101153 · Cited by 5
Sun, W., Dong, Z.-W., Zhou, Y., Jin, F., Liu, H., & Fan, L. (2023) · Microbes and Infection · doi:10.1016/j.micinf.2023.105185 · Cited by 3
Alomatu, S., Vasaikar, S. D., Thomas, K., Dubula, T., & Moeketsi, K. (2023) · Pathogens · doi:10.3390/pathogens12091175 · Cited by 3
Yan, Z., Wen, J.-X., Niu, Y., Jiang, T., Huang, J., Chen, H., Chen, Q., Wang, Y.-F., Yan, L., Hu, Z.-D., et al. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156618 · Cited by 3
Guleria, R., Chawla, R., Modi, M., Rodrigues, C. S., Jaiswal, A., Saxena, P., Biswal, M., Chaudhry, D., Peter, J. V., Sehgal, I. S., et al. (2024) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24783 · Cited by 5
Kaushik, A., Singh, J., Fatima, Z., & Hameed, S. (2025) · Drug Target Insights · doi:10.33393/dti.2025.3304 · Cited by 3
Hepatic Manifestations of Systemic Diseases
González, H. C., & Gordon, S. C. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2023.01.008 · Cited by 6
Das, S., Nischal, N., Singh, B. K., Ray, A., Jorwal, P., Soneja, M., Khan, M. A., Sikka, K., Sinha, S., & Wig, N. (2023) · Access Microbiology · doi:10.1099/acmi.0.000665.v3 · Cited by 3
Iqbal, I., Farhana, A., Zahoor, D., & Bashir, H. (2020) · Indian Journal of Microbiology Research · doi:10.18231/j.ijmr.2020.049 · Cited by 3
Moore, K., Tourneau, N. L., Alvarez, J., Rodriguez, S., Broussard, J., Crouch, P.-C., Roman, J., Defechereux, P. A., Bena, J., Koester, K. A., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-024-10384-2 · Cited by 2
Afriyie-Mensah, J. S., Aryee, R., Zigah, F., Kwarteng, E., & Séraphin, M. N. (2023) · Tuberculosis Research and Treatment · doi:10.1155/2023/6648137 · Cited by 2
Wu, G., Wang, J., Xu, X., Wei, H., Cai, L., & Liu, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31680 · Cited by 2
Wei, J., Qian, X.-Q., Wan, Y., Zhao, X., Zhang, C., Guo, W., & Zhu, Z. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09684-4 · Cited by 2
Tuberculosis prostate abscess: molecular diagnostic testing
Gómez-Jordan, S., Jarava, S., Ascencio-Guzmán, Y., & Viasus, D. (2024) · GERMS · doi:10.18683/germs.2024.1423 · Cited by 2
Randall, P. J., Mutsvangwa, J., Nliwasa, M., Wilson, L., Makamure, B., Makambwa, E., Meldau, R., Dheda, K. U. J., Munyati, S. S., Siddiqi, O. K., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae496 · Cited by 2
Self-citationThe Role of TB Biomarkers in Diagnosis, Prognosis and Prevention of Tuberculosis
Matuku-Kisaumbi, P. (2024) · Infectious diseases · doi:10.5772/intechopen.115129 · Cited by 3
Diagnosis of HIV-Associated Tuberculosis
Kerkhoff, A. D., & Cattamanchi, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-29108-2_7 · Cited by 2
Thiagarajan, D., Teh, D. A. L., Tarmidzi, N. A. A., Ishak, H., Bakar, Z. A., & Bastion, M.-L. C. (2021) · Tropical Diseases Travel Medicine and Vaccines · doi:10.1186/s40794-021-00153-3 · Cited by 2
He, Y.-G., Huang, Y., Yi, X.-L., Qian, K.-L., Wang, Y., Cheng, H., Hu, J., & Liu, Y. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i3.709 · Cited by 4
Pancreatic tuberculosis in a liver transplant recipient: a case report
Victor, D. R., Peixoto, P. H. T. M., de Medeiros, P. R. A., Neto, H. C. B., Silva, A. D. O. R., Victor, M. E. R., & Ferraz, T. L. L. (2023) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946202365044 · Cited by 2
Özkarataş, E., Özkarataş, M. H., Özkütük, A. A., & Esen, N. (2020) · Türk Mikrobiyoloji Cemiyeti Dergisi · doi:10.5222/tmcd.2020.010 · Cited by 2
Bruyn, E. D., Ruzive, S., Howlett, P. J., Jacobs, A. J., Arlehamn, C. S. L., Sette, A., Sher, A., Mayer-Barber, K. D., Barber, D. L., Mayosi, B. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.12.491749 · Cited by 2
Blood RNA signatures outperform CRP triage of tuberculosis lymphadenitis and pericarditisPreprint
Mann, T., Minnies, S., Gupta, R. K., Reeve, B. W. P., Nyawo, G. R., Palmer, Z., Naidoo, C. C., Doubell, A. F., Pecararo, A., John, T.-J., et al. (2024) · medRxiv · doi:10.1101/2024.06.21.24309099 · Cited by 2
Porcel, J. M., & Porcel, L. (2023) · Integrated science · doi:10.1007/978-3-031-15955-8_35 · Cited by 1
Sharma, S., Kaur, P., Aggarwal, A. N., Kaur, K., Yadav, R., Sethi, S. K., & Verma, I. (2024) · Letters in Applied Microbiology · doi:10.1093/lambio/ovae102 · Cited by 1
Ángel-Bran, O. A., Ponce-Gallegos, M. A., Villegas, D. A. V., Arteaga, G. S., & Cruz, J. L. B. D. L. (2026) · Cureus · doi:10.7759/cureus.103737 · Cited by 1
Xing, X., Guo, C., Zhao, G., Xie, D., Zhang, L., Shi, K., Zhang, Z., Pang, Y., & Cui, J. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s575888 · Cited by 1
Tuberculous rheumatism: A great mimic of juvenile idiopathic arthritis
Mishra, M. R., Joshi, D., Adhikari, K. M., & Dharmshale, S. (2019) · Journal of Marine Medical Society · doi:10.4103/jmms.jmms_74_18 · Cited by 1
Agrawal, S., Kant, S., Das, V., Jain, A., & Mishra, S. (2021) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1957_20 · Cited by 1
Keim‐Malpass, J., Heysell, S. K., Thomas, T. A., Lobo, J. M., Mpagama, S. G., Muzoora, C. K., & Moore, C. C. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20065041 · Cited by 2
He, X.-H., Hong, Y., Wang, C., Duan, X.-Y., Qiao, J.-J., Guo, X., Zhao, H., Ren, D., Li, J., & Zhang, Q. (2023) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v14.i3.62 · Cited by 1
Sharma, J. B., Dharmendra, S., Rapaka, G., Singh, U. B., Kriplani, A., Kumar, S., Dash, N. R., & Nayyer, R. (2023) · Journal of Minimal Access Surgery · doi:10.4103/jmas.jmas_3_23 · Cited by 1
Naser, N., Abdulla, H., & Kadhem, H. (2023) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-023-00225-0 · Cited by 1
Riquelme, O. T., & Moreno, J. (2023) · Visión Antataura · doi:10.48204/j.vian.v7n1.a3923 · Cited by 1
Diagnosis of Paediatric Extrapulmonary Tuberculosis by the MPT64 Antigen at a Tertiary Care Hospital
Kumari, R., Kumar, R., Anita, Muni, S., Kumar, S., & Kumari, N. (2024) · Cureus · doi:10.7759/cureus.55688 · Cited by 2
Randall, P. J., Esmail, A., Wilson, L., Makambwa, E., Pooran, A., Tomasicchio, M., Dheda, K. U. J., & Ntsekhe, M. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae021 · Cited by 1
Self-citationHe, Y., Li, T., Wang, P., Li, Q., Zhang, H., Jiang, L., Yang, L., & Shi, T. (2024) · Clinical and Molecular Epidemiology · doi:10.53964/cme.2024004 · Cited by 1
Extra-Pulmonary Mycobacterium tuberculosis
Shi, T., Li, T., & Xing, X. (2024) · Infectious diseases · doi:10.5772/intechopen.115393 · Cited by 1
Métodos diagnósticos de la tuberculosis
Guirao‐Arrabal, E., & Ruiz-Cabello, M. M. (2019) · Medicina Clínica · doi:10.1016/j.medcli.2019.08.001 · Cited by 1
Ancient foe spectra: Case series of Mycobacterium tuberculosis presentations
Goravey, W., Ali, G. A. M., Petkar, M. A., Ammar, A. A., Eldean, M. Z. S., Maslamani, M. A. R. S. A., & Hadi, H. A. (2020) · Clinical Case Reports · doi:10.1002/ccr3.3616 · Cited by 1
Metadata
- Authors
- Kohli, M., Schiller, I., Dendukuri, N., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R.
- Affiliations
- McGill University (CA)
- McGill University Health Centre (CA)
- University of Cape Town (ZA)
- FIND (CH)
- Liverpool School of Tropical Medicine (GB)
- Corresponding author
- Steingart, Karen R
- ORCID
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2018-08-27
- Volume
- 8
- Pages
- CD012768-CD012768
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC6513199
- OpenAlex
- W2748797449
- Cited by
- 245
- References
- 218
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 34 · 2023: 28 · 2022: 33 · 2021: 44 · 2020: 45 · 2019: 34 · 2018: 1
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Update notices
- new_version (2021-01-15)
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Funders
- Beijing University of Chinese Medicine
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- Xpert MTB/RIF, extrapulmonary tuberculosis, rifampicin resistance, Mycobacterium tuberculosis complex, diagnostic accuracy, tuberculous meningitis, pleural tuberculosis, tuberculous lymphadenitis, osteoarticular tuberculosis, urogenital tuberculosis, tuberculous pericarditis, tuberculous peritonitis, nucleic acid amplification tests, latent class analysis, sensitivity and specificity
- MeSH terms
- Antibiotics, Antitubercular, Bacterial Proteins, False Negative Reactions, False Positive Reactions, Humans, Mycobacterium tuberculosis, Reagent Kits, Diagnostic, Reference Standards, Rifampin, DNA-Directed RNA Polymerases, Sensitivity and Specificity, Tuberculosis, Tuberculosis, Meningeal, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review